Conference preview: ChinaBio Partnering Forum 2019

China is the world’s fastest-growing healthcare market and is expected to be the number one market in the world by 2020.

Cross-border partnerships are a strong focus as the China Food and Drug Administration has made international collaboration and investment easier, including foreign-approved investigational new drug application exemptions that speed up drug trials by two years or more, and expedited regulatory processes for new drugs.